Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
30,663,471
-
Share change
-
+319,008
-
Total reported value
-
$464,249,247
-
Price per share
-
$15.28
-
Number of holders
-
77
-
Value change
-
+$5,703,309
-
Number of buys
-
32
-
Number of sells
-
34
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q1 2021
As of 31 Mar 2021 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,663,471 shares of stock of the company.
Largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Vivo Capital, LLC, BlackRock Inc., Versant Venture Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, 5AM Venture Management, LLC, Point72 Asset Management, L.P., and VANGUARD GROUP INC.
This table shows 77 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.